Details for New Drug Application (NDA): 008720
✉ Email this page to a colleague
NDA 008720 describes LEVO-DROMORAN, which is a drug marketed by Valeant Pharm Intl and is included in two NDAs. Additional details are available on the LEVO-DROMORAN profile page.
The generic ingredient in LEVO-DROMORAN is levorphanol tartrate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levorphanol tartrate profile page.
The generic ingredient in LEVO-DROMORAN is levorphanol tartrate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levorphanol tartrate profile page.
Summary for 008720
| Tradename: | LEVO-DROMORAN |
| Applicant: | Valeant Pharm Intl |
| Ingredient: | levorphanol tartrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 008720
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 19, 1991 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
